Strategic Partnerships CHS has recent and notable exclusive Canadian partnerships and expansions, including a strategic exclusive Canadian commercial partnership for ScleroSafe with VVT Med and ongoing growth through acquisitions such as Respan Products Inc., Stadco Polyproducts Inc., and Velmed, expanding its distribution and manufacturing footprint.

Domestic Capacity Significant investment and government support to modernize and expand Ontario manufacturing capacity, including a $1.9M Ontario Together Fund grant and headcount growth, signaling a scalable production base in Canada to support emergency readiness and national supply security.

North American Growth Active US market expansion alongside Canadian operations, with offices and manufacturing scaling in Northern America, creating cross-border sales opportunities and broader vendor relationships in respiratory, anesthesia, interventional radiology, and other clinical categories.

Specialist Positioning Positioning as a specialized, non-distributor manufacturer and advocate for better healthcare presents a compelling case to target hospitals, non-acute care settings, and partner networks seeking vetted, outcome-focused devices with cost-reduction potential.

Product Portfolio Expansion Diverse portfolio through owned brands MED-RX and Respan plus a broad third-party representation across clinical categories, offering multiple entry points for healthcare system procurement teams and opportunities to upsell integrated device solutions and consumables.